Search for companies, drugs, and catalysts
Phase 2
Development Phase
1
Upcoming Catalysts
0
Historical Events
Regulatory Approvals
ICS-LABA Phase 2 Results Expected
ICS-LABA • Moderate to Severe Asthma
Target Indication
Moderate to Severe Asthma
Clinical Trial
Last updated: 12/4/2025
INCY
Incyte Corporation